Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 5, 2000, Pages 415-418

  Zhi, Lin ^a   Tegley, Christopher M ^a   Pio, Barbara ^a   West, Sarah J ^a   Marschke, Keith B ^a   Mais, Dale E ^a   Jones, Todd K ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 THIOPHENE 1,2 DIHYDROQUINOLINE DERIVATIVE; 6 THIOPHENE 1,2,3,4 TETRAHYDROQUINOLINE DERIVATIVE; ANTIGESTAGEN; PROGESTERONE RECEPTOR; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL MODIFICATION; DRUG EFFICACY; DRUG SYNTHESIS; HUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE; CROSS REACTIONS; FIBROBLASTS; HAPLORHINI; HUMANS; MICE; QUINOLINES; RECEPTORS, PROGESTERONE; STRUCTURE-ACTIVITY RELATIONSHIP; THIOPHENES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034611152     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00011-1     Document Type: Article

References (19)

1. Pathirana C., Stein R.B., Berger T.S., Fenical W., Ianiro T., Mais D.E., Torres A., Goldman M.E. Mol. Pharm. 47:1995;630.
2. Hamann L.G., Farmer L.J., Johnson M.G., Wang X.-N., Marschke K.B., Jones T.K. J. Med. Chem. 41:1998;623.
3. Combs D.W., Reese K., Phillips A. J. Med. Chem. 38:1995;4878.
4. Combs D.W., Reese K., Cornelius L.A., Gunnet J.W., Cryan E.V., Granger K.S., Jordan J.J., Demarest K.T. J. Med. Chem. 38:1995;4880.
5. Kurihara K., Tanabe K., Shinei R., Okonogi T., Ohtsuka Y., Omoto S. J. Antibiot. 50:1997;360.
6. Kurihara K., Tanabe K., Yamamoto Y., Shinei R., Ajito K., Okonogi T. Bioorg. Med. Chem. Lett. 9:1999;1837.
7. Kettel L.M. Clin. Obstetr. Gynecol. 38:1995;921.
8. Baulieu E.E. Ann. NY Acad. Sci. 828:1997;47.
9. Pooley C.L.F., Edwards J.P., Goldman M.E., Wang M.-W., Marschke K.B., Crombie D.L., Jones T.K. J. Med. Chem. 41:1998;3461.
10. Hamann L.G., Winn D.T., Pooley C.L.F., Tegley C.M., West S.J., Farmer L.J., Zhi L., Edwards J.P., Marschke K.B., Mais D.E., Goldman M.E., Jones T.K. Bioorg. Med. Chem. Lett. 8:1998;2731.
11. Suzuki A. Pure Appl. Chem. 63:1991;419.
12. 3) 7.79 (d, J=1.3 Hz, 1H), 7.46 (d, J=1.3 Hz, 1H), 7.20 (d, J=1.9 Hz, 1H), 7.16 (dd, J=8.0 and 1.9 Hz, 1H), 6.46 (d, J=8.0 Hz, 1H), 5.37 (s, 1H), 3.84 (bs, 1H), 2.03 (s, 3H) and 1.30 (s, 6H).
13. 3) 214.5, 143.6, 143.0, 136.3, 130.3, 126.2, 126.1, 125.2, 123.8, 116.5, 114.5, 110.6, 60.1, 47.0, 27.6 and 24.5.
14. Rosen J., Day A., Jones T.K., Jones E.T.T., Nadzan A.M., Stein R.B. J. Med. Chem. 38:1995;4855.
15. Zhi L., Tegley C.M., Marschke K.B., Mais D.E., Jones T.K. J. Med. Chem. 42:1999;1466.
16. Lorenzo D.D., Albertini A., Zava D. Cancer Res. 51:1991;4470.
17. Beck C.A., Weigel N.L., Moyer M.L., Nordeen S.K., Edwards D.P. Proc. Natl. Acad. Sci. USA. 90:1993;4441.
18. See activity differences of related nonsteroidal progestin series in CV-1 and T47D cell lines (ref 15).
19. Results of these experiments will be reported in due course.